Vaxcyte, Inc.
PCVX · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $0K | $0K | |
| Operating income | −$924M | −$570M | −62.2% |
| Net income | −$767M | −$464M | −65.2% |
Latest quarter: Q3 2026
Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 4, 2026
| $ | Q3 2026 | Year earlier | Change |
|---|---|---|---|
| Revenue | $0K | $0K | |
| Operating income | −$308M | −$242M | −27.2% |
| Net income | −$297M | −$213M | −39.6% |
Q3 2026 dashboardQ3 2026 infographic
Questions
- What was Vaxcyte's revenue in FY2025?
- $0K in FY2025 (Fiscal year ended Dec 31, 2025), no comparable figure vs $0K a year earlier, per its 10-K filed Feb 2026.
- Was Vaxcyte profitable in FY2025?
- No: net income was −$767M and operating income −$924M in FY2025.
- What was Vaxcyte's revenue in Q3 2026?
- $0K (n/a vs a year earlier), per its Form 10-Q filed Nov 4, 2026.